Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Narcan, the nasal spray version of naloxone, has received F.D.A. approval to be sold over the counter.
Simplified Text
The FDA has approved the naloxone nasal spray Narcan for over-the-counter sale.
Confidence Score
1.000
Claim Maker
The author
Context Type
News Article
Context Details
{
    "product": "Narcan",
    "organization": "F.D.A."
}
UUID
0a50b6af-bce9-4a56-9857-7e25aba4acf0
Vector Index
âś— No vector
Created
September 17, 2026 at 8:15 PM (3 weeks ago)
Last Updated
September 17, 2026 at 8:15 PM (3 weeks ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/09/16/us/uss-abraham-lincoln-fentanyl.html
https://nytimes.com/2026/09/16/us/uss-abraham-lincoln-fentanyl.html

Two former U.S. Navy service members pleaded guilty to selling fentanyl-laced counterfeit oxycodone pills to active-duty sailors, including during deployments. One sailor died from an overdose, and another was hospitalized.

Similar Claims (5)

Other claims identified as semantically similar to this one.